Pulsed Field Ablation Market: By Therapeutic Area, By Product Components, By Application Area, By Source of Ablation and Region Forecast 2019-2030
Pulsed Field Ablation Market size was valued at US$ 121.8 million in 2023 and is expected to grow at a CAGR of 38.1% from 2024 to 2030. Pulsed-field ablation (Pulsed Field Ablation) is an innovative non-thermal ablation technology primarily used in treating cardiac arrhythmias, particularly atrial fibrillation. This technique uses short, high-voltage electrical pulses to create pores in cell membranes, leading to cell death in targeted tissue while minimizing damage to surrounding structures. The increasing prevalence of cardiovascular disorders, especially atrial fibrillation, is a primary driver for the PFA market.
The potential for Pulsed Field Ablation to offer safer and more efficient ablation procedures compared to traditional thermal-based methods is fueling market growth. Ongoing research exploring Pulsed Field Ablation applications in oncology and other medical fields is expanding the market's potential. Technological advancements in catheter design and energy delivery systems contribute to improved procedural outcomes and drive adoption. The market is also benefiting from increased healthcare expenditure and a growing focus on minimally invasive procedures. However, challenges such as the high cost of Pulsed Field Ablation systems and the need for extensive clinical validation may hinder market growth.
In January 2023, Boston Scientific announced the commencement of the ADVANTAGE AF clinical trial to evaluate the safety and effectiveness of the FARAPULSE Pulsed Field Ablation System.
Study Period
2024– 2030Base Year
2023CAGR
38.1%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
The rising incidence of cardiovascular disorders, particularly atrial fibrillation, is a significant driver for the pulsed field ablation market. Pulsed Field Ablation offers potential advantages over traditional radiofrequency and cryoablation techniques, including reduced risk of collateral tissue damage and shorter procedure times. These benefits are driving adoption among electrophysiologists and healthcare providers. Furthermore, there has been increased investment in research and development to expand Pulsed Field Ablation applications beyond cardiac arrhythmias, including potential uses in cancer treatment and other medical fields. This expansion of potential therapeutic areas is expected to fuel market growth in the coming years. The COVID-19 pandemic initially slowed market growth due to postponement of elective procedures but has since led to increased focus on developing more efficient and safer medical technologies, potentially benefiting the market in the long term. However, the high cost of pulsed field ablation systems and the need for extensive clinical data to support widespread adoption may pose challenges to market growth.
North America is expected to account for the largest share of the market and maintain its dominance in the forecast period. Factors contributing to North America's leading position include advanced healthcare infrastructure, high prevalence of cardiovascular disorders, presence of key market players, and early adoption of innovative medical technologies.
European region is anticipated to show significant growth, driven by increasing awareness of Pulsed Field Ablation technology and supportive regulatory frameworks.
Asia-Pacific region is expected to exhibit the fastest growth during the forecast period, fueled by improving healthcare infrastructure, rising healthcare expenditure, and a large patient pool in countries like China and India.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024– 2030 |
|
Market Size in 2023 |
US$ 121.8 million |
|
Market CAGR |
38.1% |
|
By Therapeutic Area |
|
|
By Product Components |
|
|
By Application Area |
|
|
By Source of Ablation |
|
|
By Region |
|
Download Free Sample Report
The pulsed field ablation market was valued at US$ 121.8 million in 2023 and is expected to grow at a CAGR of 38.1% from 2024 to 2030.
Asia-Pacific region is expected to exhibit the fastest growth during the forecast period
The leading players in the global Pulsed Field Ablation Market are Medtronic, Boston Scientific Corporation, Abbott Laboratories, Johnson & Johnson, Biosense Webster, AtriCure, Inc., Acutus Medical, Inc., AngioDynamics, Inc., Galvanize Therapeutics, Inc., and Adagio Medical, Inc.
| 1. Executive Summary |
| 2. Global Pulsed Field Ablation Market Introduction |
| 2.1.Global Pulsed Field Ablation Market - Taxonomy |
| 2.2.Global Pulsed Field Ablation Market - Definitions |
| 2.2.1.Therapeutic Area |
| 2.2.2.Product Components |
| 2.2.3.Application Area |
| 2.2.4.Source of Ablation |
| 2.2.5.Region |
| 3. Global Pulsed Field Ablation Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Pulsed Field Ablation Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Pulsed Field Ablation Market By Therapeutic Area, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Cardiovascular Disorders |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Oncological Disorders |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Respiratory Disorders |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Dermatological Disorders |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global Pulsed Field Ablation Market By Product Components, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Catheter |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Generator |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Global Pulsed Field Ablation Market By Application Area, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Ablation |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Ablation and Mapping |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8. Global Pulsed Field Ablation Market By Source of Ablation, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Pulsed Field Energy |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Pulsed Field and Radiofrequency Energy |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Pulsed Field and Cryoablation Energy |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9. Global Pulsed Field Ablation Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Pulsed Field Ablation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Cardiovascular Disorders |
| 10.1.2.Oncological Disorders |
| 10.1.3.Respiratory Disorders |
| 10.1.4.Dermatological Disorders |
| 10.2. Product Components Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Catheter |
| 10.2.2.Generator |
| 10.3. Application Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Ablation |
| 10.3.2.Ablation and Mapping |
| 10.4. Source of Ablation Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Pulsed Field Energy |
| 10.4.2.Pulsed Field and Radiofrequency Energy |
| 10.4.3.Pulsed Field and Cryoablation Energy |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11. Europe Pulsed Field Ablation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Therapeutic Area Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Cardiovascular Disorders |
| 11.1.2.Oncological Disorders |
| 11.1.3.Respiratory Disorders |
| 11.1.4.Dermatological Disorders |
| 11.2. Product Components Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Catheter |
| 11.2.2.Generator |
| 11.3. Application Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Ablation |
| 11.3.2.Ablation and Mapping |
| 11.4. Source of Ablation Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Pulsed Field Energy |
| 11.4.2.Pulsed Field and Radiofrequency Energy |
| 11.4.3.Pulsed Field and Cryoablation Energy |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12. Asia Pacific (APAC) Pulsed Field Ablation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Therapeutic Area Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Cardiovascular Disorders |
| 12.1.2.Oncological Disorders |
| 12.1.3.Respiratory Disorders |
| 12.1.4.Dermatological Disorders |
| 12.2. Product Components Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Catheter |
| 12.2.2.Generator |
| 12.3. Application Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Ablation |
| 12.3.2.Ablation and Mapping |
| 12.4. Source of Ablation Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Pulsed Field Energy |
| 12.4.2.Pulsed Field and Radiofrequency Energy |
| 12.4.3.Pulsed Field and Cryoablation Energy |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13. Middle East and Africa (MEA) Pulsed Field Ablation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Therapeutic Area Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Cardiovascular Disorders |
| 13.1.2.Oncological Disorders |
| 13.1.3.Respiratory Disorders |
| 13.1.4.Dermatological Disorders |
| 13.2. Product Components Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Catheter |
| 13.2.2.Generator |
| 13.3. Application Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Ablation |
| 13.3.2.Ablation and Mapping |
| 13.4. Source of Ablation Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Pulsed Field Energy |
| 13.4.2.Pulsed Field and Radiofrequency Energy |
| 13.4.3.Pulsed Field and Cryoablation Energy |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America Pulsed Field Ablation Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Therapeutic Area Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Cardiovascular Disorders |
| 14.1.2.Oncological Disorders |
| 14.1.3.Respiratory Disorders |
| 14.1.4.Dermatological Disorders |
| 14.2. Product Components Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Catheter |
| 14.2.2.Generator |
| 14.3. Application Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Ablation |
| 14.3.2.Ablation and Mapping |
| 14.4. Source of Ablation Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Pulsed Field Energy |
| 14.4.2.Pulsed Field and Radiofrequency Energy |
| 14.4.3.Pulsed Field and Cryoablation Energy |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Medtronic |
| 15.2.2.Boston Scientific Corporation |
| 15.2.3.Abbott Laboratories |
| 15.2.4.Johnson & Johnson |
| 15.2.5.Biosense Webster (a Johnson & Johnson company) |
| 15.2.6.AtriCure, Inc. |
| 15.2.7.Acutus Medical, Inc. |
| 15.2.8.AngioDynamics, Inc. |
| 15.2.9.Galvanize Therapeutics, Inc. |
| 15.2.10.Adagio Medical, Inc. |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
